Amyloid and tau positive mild cognitive impairment: clinical and biomarker characteristics of dementia progression
Lists
Only you see this
Abstract
In future clinical trials, specific CSF and cognitive measures that predict dementia progression in A+T+MCI might be useful risk factors for assessing the risk of dementia progression.
BibTeX
@inproceedings{wei2021amyloid,
author = {Hongchun Wei and Bing Li and Kok Pin Ng and Qingxi Fu and Shengjie Dong and Maowen Ba and Min Kong},
title = {{Amyloid and tau positive mild cognitive impairment: clinical and biomarker characteristics of dementia progression}},
booktitle = {Chinese},
year = {2021},
doi = {10.1097/cm9.0000000000001496},
}Loading related content...